This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Yuhan Corporation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Mind of Yoo Hoi Park
Introduction: Yoo Hoi Park is a distinguished inventor based in Suwon-si, South Korea, known for his significant contributions to the field of pharmaceutical chemistry. With a keen focus on advancing medical science, he has successfully developed innovative compounds that hold promise in treating various health conditions.
Latest Patents: Yoo Hoi Park holds a patent for pyrrolidine and piperidine compounds, which are known for their pharmaceutically acceptable salts and preparation processes. This patent outlines the formulation of pharmaceutical compositions containing these compounds and emphasizes their potential applications in the treatment and prevention of diseases mediated by familial amyloid polyneuropathy (FAP).
Career Highlights: Throughout his career, Yoo Hoi Park has demonstrated a commitment to innovation in the pharmaceutical industry. His work at Yuhan Corporation, a leading company in Korea, showcases his expertise and dedication to creating impactful medical solutions. His contributions have not only enhanced his professional stature but also provided essential advancements in therapeutic treatments.
Collaborations: As part of a dynamic team at Yuhan Corporation, Yoo Hoi Park collaborates with talented colleagues like Tae Han Dong and Tae Kyun Kim. Together, they push the boundaries of pharmaceutical research, focusing on the development of novel compounds that can substantially improve patient outcomes.
Conclusion: Yoo Hoi Park's innovative work in the creation of pyrrolidine and piperidine compounds exemplifies the crucial role inventors play in the advancement of medical science. His endeavors at Yuhan Corporation and collaborative approach reflect a dedication to enhancing healthcare through innovative inventions. With continued research and development, Park’s contributions are sure to impact the pharmaceutical landscape positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
